![[feed]](/style/images/feed-icon-14x14.png){kind=icon}
Rothschedl, E. and Nachtnebel, A. (2015): Horizon Scanning in Oncology 23rd Prioritisation – 2nd quarter 2015. HSO: 23rd Prioritisation.
Preview |
PDF
- Sie müssen einen PDF-Viewer auf Ihrem PC installiert haben wie z. B. GSview, Xpdf oder Adobe Acrobat Reader
458kB |
Abstract
For the 23rd prioritisation (June 2015), 10 drugs were filtered out of 170 identified and were sent to prioritisation. Of these, 4 drugs were ranked as "highly relevant" by the expert panel, 5 as "relevant" and 1 as "not relevant". For "highly relevant" drugs, further information including, for example, abstracts of phase III studies and licensing status is contained in this document.
| Item Type: | DSD: Horizon Scanning in Oncology |
|---|---|
| Subjects: | WB Practice of medicine > WB 300-962 Therapeutics QZ Pathology > QZ 200-380 Neoplasms.Cysts QV Pharmacology, toxicology, pharmacy > QV 60-370 Pharmacology |
| Language: | English |
| Series Name: | HSO: 23rd Prioritisation |
| Deposited on: | 17 Aug 2015 10:10 |
| Last Modified: | 10 Jul 2025 11:25 |
Repository Staff Only: item control page